Profound Medical Corp. stock is up 1.46% since 30 days ago. The next earnings date is Mar 7, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 0% of the previous 7 March’s closed higher than February.
Profound Medical Corp. develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment. Its lead product TULSA-PRO system used for magnetic resonance imaging scanner in hospitals and treatment facilities.
Unlock Exclusive Market Insights! Receive timely updates on market developments. Sign up & stay informed!